Clinical Trials in New York

Showing 6541-6560 of 22,668 trials

Ibrutinib and Brentuximab Vedotin in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma

NCT02744612

This phase II trial studies how well ibrutinib and brentuximab vedotin work in treating patients with Hodgkin lymphoma that has returned (relapsed) or does not respond to treatment (refractory). Ibrutinib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Immunotherapy with monoclonal antibodies, such as brentuximab vedotin, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Giving ibrutinib together with brentuximab vedotin may be a better treatment for Hodgkin lymphoma.

Recurrent Hodgkin LymphomaRefractory Hodgkin Lymphoma

City of Hope Medical Center39 participantsStarted Jun 2016

Duarte, California, United States • New York, New York, United States • Columbus, Ohio, United States

TERMINATEDPhase 1/2< 1 mile

Phase 1/2 Study of OBI-999 in Patients With Advanced Solid Tumors

NCT04084366

The purpose of this study is to establish the maximum tolerated dose (MTD) and recommended phase 2 dose (RP2D) of OBI-999 as monotherapy, and to characterize the safety and preliminary clinical activity profile of the RP2D of OBI-999 in patients with advanced solid tumors.

Locally Advanced Solid Tumor

OBI Pharma, Inc44 participantsStarted Nov 2019

La Jolla, California, United States • New York, New York, United States • Germantown, Tennessee, United States +1 more locations

RECRUITINGPhase 2< 1 mile

Phase 2 Trial of Voyager V1 in Combination With Cemiplimab in Cancer Patients

NCT04291105

This is a Phase 2 study designed to determine the preliminary anti-tumor activity and confirm the safety of VV1 in combination with cemiplimab. The study will enroll patients with three distinct separate tumor cohorts. The cancers types are colorectal, head and neck carcinoma, and melanoma that are progressing on CPI treatment.

MelanomaHead and Neck Squamous Cell CarcinomaColo-rectal Cancer

Vyriad, Inc.87 participantsStarted Apr 2020

Phoenix, Arizona, United States • Durate, California, United States • Los Angeles, California, United States +24 more locations

Ibrutinib and Brentuximab Vedotin in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma

Phase 1/2 Study of OBI-999 in Patients With Advanced Solid Tumors

Phase 2 Trial of Voyager V1 in Combination With Cemiplimab in Cancer Patients

Find Trials by Condition in New York

Adjuvant Hepatic Arterial Infusion and Combination Chemotherapy in Treating Patients With Resectable Hepatic Metastases From Colorectal Cancer

Efficacy Against Oral Persistent Infection, Immunogenicity and Safety of the 9-valent Human Papillomavirus Vaccine (9vHPV) in Men Aged 20-45 Years (V503-049)

Safety and Efficacy of the SurVeil™ Drug-Coated Balloon

Special Care Patterns for Elderly HNSCC Patients Undergoing Radiotherapy

Efficacy and Safety Study of Narsoplimab in Pediatric Patients With High-Risk Hematopoietic Stem Cell Transplant TMA

Safety and Efficacy of BHV-3000 (Rimegepant) Orally Disintegrating Tablet for the Acute Treatment of Chronic Rhinosinusitis

Maximum Tolerated Dose, Safety, and Efficacy of Rhenium Nanoliposomes in Recurrent Glioma (ReSPECT)

Comparison of Surgeons' Object Discernment Via Their Hands Versus Using a Robotic Surgical System That Does Not Incorporate Haptics

A Study of Multiple Sclerosis Routine Clinical Practice: Impact on Adherence and Clinical Outcomes of Ofatumumab Treated Patients

Study of NIS793 and Other Novel Investigational Combinations With SOC Anti-cancer Therapy for the 2L Treatment of mCRC

Oxytocin and Brain Responses in Maternal Addiction

PArtial REbreathing for Migraine With Aura 1

Optimal Post Tpa-Iv Monitoring in Ischemic Stroke

Walking and mHealth to Increase Participation in Parkinson Disease

BURAN: Benralizumab on Airway Dynamics in Severe Eosinophilic Asthma Using Functional Respiratory Imaging

Urine CXCL10 Monitoring Trial in Kidney Transplant

Efficacy of Emotionally Focused Therapy Among Spanish Speaking Couples